Immunopathologic processes in sympathetic ophthalmia as signified by microRNA profiling

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 7, 2012, Pages 4197-4204

  Kaneko, Yutaka ^a   Wu, Guey Shuang ^a   Saraswathy, Sindhu ^a   Vasconcelos Santos, Daniel V ^b   Rao, Narsing A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MICRORNA; MICRORNA 1; MICRORNA 182; MICRORNA 9; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MICROSCOPY; OXIDATIVE STRESS; PHOTORECEPTOR; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SYMPATHETIC OPHTHALMIA; UPREGULATION; BIOSYNTHESIS; CHOROID; COMPARATIVE STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CHOROID; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; MIDDLE AGED; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPHTHALMIA, SYMPATHETIC; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866284865     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9465     Document Type: Article

References (44)

1. Goto H, Rao NA. Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin. 1990;30:279-285.
2. Power WJ, Foster CS. Update on sympathetic ophthalmia. Int Ophthalmol Clin. 1995;35:127-137.
3. Makley TA Jr, Azar A. Sympathetic ophthalmia. A long-term follow-up. Arch Ophthalmol. 1978;96:257-262.
4. O'Driscoll L. The emerging world of microRNAs. Anticancer Res. 2006;26:4271-4278.
5. Rajewsky N, Socci ND. Computational identification of micro-RNA targets. Dev Biol. 2004;267:529-535.
6. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell. 2003;113:25-36.
7. Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005;15:563-568.
8. Eisenberg I, Eran A, Nishino I, et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A. 2007;104:17016-17021.
9. Ikeda S, Kong SW, Lu J, et al. Altered microRNA expression in human heart disease. Physiol Genomics. 2007;31:367-373.
10. McManus MT. MicroRNAs and cancer. Semin Cancer Biol. 2003;13:253-258.
11. Hansen T, Olsen L, Lindow M, et al. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE. 2007;2:e873.
12. Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE. 2007;2:e610.
13. Furer V, Greenberg JD, Attur M, Abramson SB, Pillinger MH. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol. 2010;136:1-15.
14. Esau CC, Monia BP. Therapeutic potential for microRNAs. Adv Drug Deliv Rev. 2007;59:101-114.
15. Czech MP. MicroRNAs as therapeutic targets. N Engl J Med. 2006;354:1194-1195.
16. von Weizsacker F, Labeit S, Koch HK, Oehlert W, Gerok W, Blum HE. A simple and rapid method for the detection of RNA in formalin-fixed, paraffin-embedded tissues by PCR amplification. Biochem Biophys Res Commun. 1991;174:176-180.
17. Lewis F, Maughan NJ, Smith V, Hillan K, Quirke P. Unlocking the archive-gene expression in paraffin-embedded tissue. J Pathol. 2001;195:66-71.
18. Zhang X, Chen J, Radcliffe T, LeBrun DP, Tron VA, Feilotter H. An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J Mol Diagn. 2008;10:513-519.
19. Jarzab M, Rozanowski P, Kowalska M, et al. Optimization of the method of RNA isolation from paraffin blocks to assess gene expression in breast cancer. Pol J Pathol. 2008;59:85-91.
20. Linton K, Hey Y, Dibben S, et al. Methods comparison for highresolution transcriptional analysis of archival material on Affymetrix Plus 2.0 and Exon 1.0 microarrays. Biotechniques. 2009;47:587-596.
21. Arzt L, Kothmaier H, Quehenberger F, et al. Evaluation of formalin-free tissue fixation for RNA and microRNA studies. Exp Mol Pathol. 2011;91:490-495.
22. Rosenwald S, Gilad S, Benjamin S, et al. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Mod Pathol. 2010;23:814-823.
23. Enquobahrie DA, Abetew DF, Sorensen TK, Willoughby D, Chidambaram K, Williams MA. Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2011;204:178.e12-21.
24. Annunziata CM, Stavnes HT, Kleinberg L, et al. Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Cancer. 2010;116:3276-3284.
25. Jones SW, Watkins G, Le Good N, et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage. 2009;17:464-472.
26. Bazzoni F, Rossato M, Fabbri M, et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci U S A. 2009;106:5282-5287.
27. Lindberg RL, Hoffmann F, Mehling M, Kuhle J, Kappos L. Altered expression of miR-17-5p in CD4{thorn} lymphocytes of relapsing-remitting multiple sclerosis patients. Eur J Immunol. 2010;40:888-898.
28. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 microRNA, and IL6 links inflammation to cell transformation. Cell. 2009;139:693-706.
29. O'Neill LA. Outfoxing Foxo1 with miR-182. Nat Immunol. 2010;11:983-984.
30. Fukunaga K, Ishigami T, Kawano T. Transcriptional regulation of neuronal genes and its effect on neural functions: expression and function of forkhead transcription factors in neurons. J Pharmacol Sci. 2005;98:205-211.
31. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104:487-501.
32. Carreras MC, Franco MC, Peralta JG, Poderoso JJ. Nitric oxide, complex I, and themodulation ofmitochondrial reactive species in biology and disease. Mol Aspects Med. 2004;25:125-139.
33. Turrens JF, Alexandre A, Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys. 1985;237:408-414.
34. Crow JP, Beckman JS. The importance of superoxide in nitric oxide-dependent toxicity: evidence for peroxynitrite mediated injury. Adv Exp Med Biol. 1996;387:147-161.
35. Palexas GN, Sussman G, Welsh NH. Ocular and systemic determination of IL-1 beta and tumour necrosis factor in a patient with ocular inflammation. Scand J Immunol Suppl. 1992;11:173-175.
36. Parikh JG, Saraswathy S, Rao NA. Photoreceptor oxidative damage in sympathetic ophthalmia. Am J Ophthalmol. 2008; 146:866-875.
37. Hayden MS, West AP, Ghosh S. NF-kappaB and the immune response. Oncogene. 2006;25:6758-6780.
38. Perrot-Applanat M, Vacher S, Toullec A, et al. Similar NF-jB gene signatures in TNF-a treated human endothelial cells and breast tumor biopsies. PLoS One. 2011;6:e21589.
39. Rajendram R, Saraswathy S, Rao NA. Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis. Br J Ophthalmol. 2007;91:531-537.
40. Khurana RN, Parikh JG, Saraswathy S, Wu GS, Rao NA. Mitochondrial oxidative DNA damage in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2008;49:3299-3304.
41. Wu GS, Lee TD, Moore RE, Rao NA. Photoreceptor mitochondrial tyrosine nitration in experimental uveitis. Invest Ophthalmol Vis Sci. 2005;46:2271-2281.
42. Saraswathy S, Rao NA. Mitochondrial proteomics in experimental autoimmune uveitis oxidative stress. Invest Ophthalmol Vis Sci. 2009;50:5559-5566.
43. Takeshita F, Patrawala L, Osaki M, et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther. 2010;18:181-187.
44. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010;327:198-201.